Atlas Trials

Study to Assess the Occurrence of HPA-1a Alloimmunization in Women With Higher Risk for Fetal and Neonatal Alloimmune Thrombocytopenia

Clinical trial NCT05345561 · COMPLETED

Trial details

NCT number
NCT05345561
Sponsor
Rallybio
Status
COMPLETED
Study type
OBSERVATIONAL
Fetal and Neonatal Alloimmune Thrombocytopenia
Start date
2022-03-14
Primary completion
2025-01-31
Enrollment
14390

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.